<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Episode 477: A Boatload of Data on Omega-3 Benefits</title>
  <description>This week, Dr. Kahn dives into four new research papers on omega-3 fatty acids and their impact on heart and brain health. The discussion highlights several eye-opening findings, including reduced atrial fibrillation risk and improved cardiovascular outcomes in patients undergoing hemodialysis. Dr. Kahn also explains how omega-3 intake supports brain health and why the “right” dose depends on the specific condition being addressed. Food sources, fish oil, algae-based supplements, and ahiflower are compared as practical ways to reach optimal omega-3 levels.&amp;amp;nbsp; Additional topics in this episode include newly approved AI software for early detection of heart disease, the role of statins in patients with type 2 diabetes, the science—and hype—around NAD+ boosters, and emerging data on Prolon fasting for Crohn’s disease. Dr. Kahn also reviews concerning research on heart rhythm risks associated with high-intensity endurance exercise in athletes over the age of 50. As always, the episode blends cutting-edge research with real-world clinical insight to help clarify what actually matters for long-term heart health. Thanks to The Fresh Pressed Olive Oil Club — get a bottle for $1 at getfreshDRKAHN.com.&amp;amp;nbsp; More About This Episode This episode takes a deeper look at why omega-3 blood levels matter more than simply taking a supplement. Dr. Kahn reviews large population studies linking higher omega-3 levels to lower risks of atrial fibrillation, early-onset dementia, and major cardiovascular events, including in high-risk groups such as patients on hemodialysis. The key takeaway: testing omega-3 status and personalizing intake may be far more effective than a one-size-fits-all approach.&amp;amp;nbsp; Beyond omega-3s, Dr. Kahn explores several timely and surprising topics, including AI-enhanced CT scan technology designed to detect silent heart disease without additional radiation, real-world data on statin benefits in patients with type 2 diabetes, and why costly NAD+ supplements may ultimately function as a form of vitamin B3. The episode also examines new evidence on fasting-mimicking diets for Crohn’s disease and potential heart rhythm risks in high-level endurance athletes over 50. Throughout the discussion, Dr. Kahn emphasizes practical, evidence-based steps patients can review with their physicians, including omega-3 blood testing, coronary calcium scoring, and tailoring lifestyle and supplement strategies to individual risk factors. </description>
  <author_name>Heart Doc VIP with Dr. Joel Kahn</author_name>
  <author_url>https://www.kahnlongevitycenter.com/</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39795255/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/39795255</thumbnail_url>
</oembed>
